News | Breast Density | March 24, 2016 | Jeff Zagoudis

State now requires notification for all patients, regardless of personal fibroglandular density levels

Indiana, breast density notification law, 2016

March 23, 2016 — Indiana Gov. Mike Pence signed an amendment to the state’s 2013 breast density reporting bill Wednesday expanding the requirements for notification. The amended law goes into effect July 1, 2016.

The state had previously enacted Senate Enrolled Act (SEA) 414 three years ago, which required notification in the mammography report if a patient was determined to have dense fibroglandular breast tissue. SEA 414 also required the provision of insurance coverage for supplemental screening for women at least 40 years old determined to have high breast density.

“We never considered it a density reporting bill as the wording stated that women would be notified about their dense tissue only if they needed further follow-up or testing,” said Nancy Cappello, Ph.D., director and founder of advocacy group Are You Dense of the existing legislation. “Density reporting should not be contingent on anything other than reporting the woman’s breast tissue composition.”

The new amendment, designated House Bill (HB) 1272, removes the specific language that only required notification if high breast density was determined. All mammography reports must now include information about fibroglandular breast density, regardless of whether or not the patient is determined to be fibroglandularly dense.

With the approval, Indiana becomes the 25th state to adopt a full breast density notification law. Three other states — New Hampshire, Vermont and Mississippi — have introduced bills in 2016, and a total of eight states are currently debating similar legislation.

For more information: www.areyoudenseadvocacy.org


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now